A Double-Blind, Randomized Study to Compare Onabutuliumtoxin A Versus Kenalog for Intravaginal Trigger Point Injections in the Treatment of Chronic Pelvic Pain
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Botulinum toxin A (Primary) ; Triamcinolone
- Indications Pelvic pain
- Focus Therapeutic Use
- 20 Mar 2017 Planned End Date changed from 1 May 2017 to 1 May 2018.
- 20 Mar 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2018.
- 02 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.